Argenx Se (ARGX) EPS (Diluted) Growth (3y) (2025 - 2026)

Argenx Se (ARGX) EPS (Diluted) Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 7.01%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.90%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 61.64%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 36.83%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.99%
7 Royalty Pharma 33.72 Bn 35.84 Bn - -36.81%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 36.39%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 67.51%
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 83.94%
Mar 31, 2026 118.20%
Dec 31, 2025 124.85%